EIF2B4 and neoplasm: These impaired malignant phenotypes induced by EIF2B4 loss were likely associated with a pronounced cell cycle arrest (Fig. 4K, L), which aligned with bioinformatic predictions that EIF2B4 fuels tumor progression by accelerating proliferation through its canonical translational role [22].